A statement released earlier today by Mizuho Securities about McKesson (NYSE:MCK) drops the target price to $183.00
- Updated: September 25, 2016
Having a price of $167.08, McKesson (NYSE:MCK) traded -0.62% lower on the day. With the last close down -6.51% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. MCK has recorded a 50-day average of $183.64 and a two hundred day average of $178.71. Trade Volume was down over the average, with 1,265,400 shares of MCK changing hands under the typical 1,522,480
Reporting as potential upside of 0.10%, Mizuho Securities dropped the price target of McKesson (NYSE:MCK) to $183.00
Recent Performance Chart
McKesson has PE ratio of 17.35 with a one year low of $148.29 and a one year high of $202.20 and has a market capitalization of $0.
A total of 15 analysts have released a report on McKesson. Four analysts rating the company a strong buy, seven analysts rating the company a buy, seven analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $195.93.
General Company Details For McKesson (NYSE:MCK)
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.